当前位置： SCI文献检索 > ANNALS OF NEUROLOGY期刊下所有文献 > Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?

Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?

Abstract：

OBJECTIVE:To study antibody-independent contributions of B cells to inflammatory disease activity, and the immune consequences of B-cell depletion with rituximab, in patients with multiple sclerosis (MS). METHODS:B-Cell effector-cytokine responses were compared between MS patients and matched controls using a 3-signal model of activation. The effects of B-cell depletion on Th1/Th17 CD4 and CD8 T-cell responses in MS patients were assessed both ex vivo and in vivo, together with pharmacokinetic/pharmacodynamic studies as part of 2 rituximab clinical trials in relapsing-remitting MS. RESULTS:B Cells of MS patients exhibited aberrant proinflammatory cytokine responses, including increased lymphotoxin (LT):interleukin-10 ratios and exaggerated LT and tumor necrosis factor (TNF)-alpha secretion, when activated in the context of the pathogen-associated TLR9-ligand CpG-DNA, or the Th1 cytokine interferon-gamma, respectively. B-Cell depletion, both ex vivo and in vivo, resulted in significantly diminished proinflammatory (Th1 and Th17) responses of both CD4 and CD8 T cells. Soluble products from activated B cells of untreated MS patients reconstituted the diminished T-cell responses observed following in vivo B-cell depletion in the same patients, and this effect appeared to be largely mediated by B-cell LT and TNFalpha. INTERPRETATION:We propose that episodic triggering of abnormal B-cell cytokine responses mediates 'bystander activation' of disease-relevant proinflammatory T cells, resulting in new relapsing MS disease activity. Our findings point to a plausible mechanism for the long-recognized association between infections and new MS relapses, and provide novel insights into B-cell roles in both health and disease, and into mechanisms contributing to therapeutic effects of B-cell depletion in human autoimmune diseases, including MS.

journal_name

Ann Neurol

journal_title

Annals of neurology

authors

Bar-Or A,Fawaz L,Fan B,Darlington PJ,Rieger A,Ghorayeb C,Calabresi PA,Waubant E,Hauser SL,Zhang J,Smith CH

doi

10.1002/ana.21939

subject

Has Abstract

pub_date

2010-04-01 00:00:00

pages

452-61

issue

eissn

0364-5134

issn

1531-8249

journal_volume

pub_type

杂志文章,随机对照试验

在线工具

Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?